These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 221547)

  • 21. Production of monoclonal antibodies by hybridomas sensitized to sporozoites of Plasmodium berghei.
    Danforth HD; Campbell GH; Leef MF; Beaudoin RL
    J Parasitol; 1982 Dec; 68(6):1029-33. PubMed ID: 6129292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and potential use of monoclonal antibodies against polio viruses.
    Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
    Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay for detecting antibodies against murine malarial parasite antigens: monoclonal antibodies recognizing Plasmodium yoelii antigens.
    Kim KJ; Taylor DW; Evans CB; Asofsky R
    J Immunol; 1980 Dec; 125(6):2565-9. PubMed ID: 7430638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Karyotype analysis of hybridomas producing monoclonal antibodies against different antigens.
    Kontsek P; Novák M; Kontseková E
    Folia Biol (Praha); 1988; 34(2):99-104. PubMed ID: 3396730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
    Majidi J; Hassan ZM
    Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A CD5+ B cell hybridoma derived factor(s), which induces maturation of CD5+, idiotype-specific B-cell populations.
    Gibson M; Hardin JA; Sherr DH
    J Mol Cell Immunol; 1990; 4(5):241-51; discussion 251-3. PubMed ID: 1698380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against tumour-associated antigens: mycoplasma as a major technical obstacle and its possible circumvention by azaserine selection medium.
    Karsten U; Rudolph M
    Arch Geschwulstforsch; 1985; 55(5):305-10. PubMed ID: 4062491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies: technology and potential use.
    Antczak DF
    J Am Vet Med Assoc; 1982 Nov; 181(10):1005-10. PubMed ID: 6757209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production of antibodies against measles virus and HBs antigen by use of the mouse hybridoma technique (author's transl)].
    Togashi T; Kuwajima S; Takebayashi T; Itoh H; Kato T
    Uirusu; 1981 Dec; 31(2):145-52. PubMed ID: 7336577
    [No Abstract]   [Full Text] [Related]  

  • 35. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.
    Yoshida N; Nussenzweig RS; Potocnjak P; Nussenzweig V; Aikawa M
    Science; 1980 Jan; 207(4426):71-3. PubMed ID: 6985745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.
    Parks DR; Bryan VM; Oi VT; Herzenberg LA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1962-6. PubMed ID: 287037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.
    Yoneda T; Mundy GR
    Calcif Tissue Int; 1982 Mar; 34(2):204-8. PubMed ID: 6177386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteoclast activating factor (OAF)].
    Kamihagi K; Katayama M; Kato I
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():756-8. PubMed ID: 8753352
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies: a powerful new tool in biology and medicine.
    Yelton DE; Scharff MD
    Annu Rev Biochem; 1981; 50():657-80. PubMed ID: 6791578
    [No Abstract]   [Full Text] [Related]  

  • 40. Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons.
    Staehelin T; Durrer B; Schmidt J; Takacs B; Stocker J; Miggiano V; Stähli C; Rubinstein M; Levy WP; Hershberg R; Pestka S
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1848-52. PubMed ID: 6165019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.